Literature DB >> 5477307

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

N E Andén, S G Butcher, H Corrodi, K Fuxe, U Ungerstedt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5477307     DOI: 10.1016/0014-2999(70)90006-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  221 in total

1.  Effect of pimozide, a dopaminergic blocking agent, on hypothalamic luteinizing hormone releasing hormone activity in hypophysectomized rats.

Authors:  A Corbin; C W Beattie; G V Upton
Journal:  Experientia       Date:  1975-05-15

2.  Facilitation of self-stimulation of the prefrontal cortex in rats following chronic administration of spiroperidol or amphetamine.

Authors:  A Robertson; G J Mogenson
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

3.  Chromopharmacological study of neuroleptics. III. Circadian rhythm of brain susceptibility to haloperidol.

Authors:  H Nagayama; A Takagi; Y Sakurai; S Yoshimoto; K Nishiwaki; R Takahasi
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

4.  Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems.

Authors:  B Scatton; A Boireau; C Garret; J Glowinski; L Julou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-01       Impact factor: 3.000

Review 5.  Pharmacology and biochemistry of haloperidol.

Authors:  C J Niemegeers; P M Laduron
Journal:  Proc R Soc Med       Date:  1976

6.  Hypothermic action of bromocriptine.

Authors:  D B Calne; L E Claveria; J L Reid
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

7.  Commentary on: "Stereotyped activities produced by amphetamine in several animal species and man." Psychopharmacologia (1967) 11:300-310. A landmark publication from the early days of the dopamine hypothesis.

Authors:  R Fog; A Randrup
Journal:  Psychopharmacology (Berl)       Date:  2002-08       Impact factor: 4.530

8.  L-dopa and arousal.

Authors:  T B Horvath; R A Meares
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

Review 9.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Selective brain noradrenaline depletion induced by the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) does not prevent the memory facilitation induced by a muscarinic agonist in mice.

Authors:  I B Introini; C M Baratti; P Huygens
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.